SlideShare a Scribd company logo
1 of 49
David
David
Geffen
Geffen
School of
School of
Medicine
Medicine

            Imaging for Prostate Cancer


                Daniel J A Margolis, MD
               Co-Director, Prostate MRI
            Assistant Professor of Radiology
            UCLA Geffen School of Medicine
Imaging For Prostate Cancer:
David
            Background
Geffen
School of
             A 2011 Harvard study found that a
Medicine
              quarter of men with low risk cancer
              received scans they did not “need”
             A number of high-risk men do not get
              the scans needed to plan treatment
             Newer modalities such as MRI and PET
              are not widely used
Imaging for Prostate Cancer:
David
            Considerations
Geffen
School of
             Whether a man needs imaging, and
Medicine
              what kind, is based on risk
                 PSA
                 Number and % of positive biopsies and
                 Grade of cancer on biopsy
                 Age and overall health
             Imaging for staging benefits high risk
              more than low risk
             Imaging can also be used to localize
              cancer within (& around) the prostate
Imaging Types
David
Geffen
School of
             Prostate and surrounding tissue
Medicine
               Color power Doppler ultrasound (PDUS)
               Magnetic resonance imaging (MRI)
               Shear wave ultrasound elastography
             Bones and lymph nodes
                 Computed tomography (CT)
                 Radionuclide (planar) bone scan (RBS)
                 Positron emission tomography (PET)
                 MRI
Ultrasound
David
Geffen
School of
             Courtesy Duke Bahn
Medicine
Ultrasound
David
Geffen
School of
             Regular gray-scale ultrasound can
Medicine
              identify cancer, but cannot
              discriminate it from benign changes
             Because of the abnormal blood supply,
              a Doppler signal shift is seen with
              prostate cancer on PDUS
               However, whether this results in increased
                detection varies by institution
             Ultrasound IV contrast dye increases
              yield, but is not approved in the USA
Ultrasound Elastography
David
Geffen
School of   From the
Medicine
            American
            Journal of
            Roentgen-
            ology
Ultrasound Elastography
David
Geffen
School of
             Elastography is the measurement of
Medicine
              the stiffness of tissue
               Cancers are stiffer than normal tissue
             New elastographic techniques
              measure the shear wave tissue
              properties of ultrasound using
              Young’s modulus
             Biopsy detection yield improves
             This may identify men who do not
              need biopsies, but this is unknown
Prostate MRI: Why?
David
Geffen
School of
             The decision to remove the prostate
Medicine      surgically vs. radio/chemotherapy is
              based primarily on clinical factors
               PSA
               Biopsy
               Physical Examination
             These factors cannot reliably tell if the
              cancer has spread beyond the
              prostate, nor on which side
             Systematic biopsies can and often do
              miss the most aggressive tumors
Background: Prostate Cancer
David
            Statistics– Screening
Geffen
School of
Medicine

             Breast cancer has
              the mammogram
             Colon cancer has
              colonoscopy




               Courtesy AdMeTech.org
Prostate MRI
David
Geffen
School of
Medicine                     Anatomy


                           Chemical
                           concentrations


                Cellular density

                                   Blood flow
What is MRI
David
Geffen
School of
             Magnetic Resonance Imaging uses
Medicine
              magnetic pulses to generate images of
              tissue in the body
             Images can be based on inherent
              magnetic properties of tissue to
              delineate anatomy or on functional
              parameters
               Blood flow
               Cellular packing and disorder
               Concentrations of chemicals
Components of MRI
David
Geffen
School of
             T2-weighted imaging for anatomy
Medicine
             Diffusion-weighted imaging to
              evaluate cellular packing and disorder
             Perfusion (dynamic contrast) imaging
              for blood flow
             Spectroscopic imaging to measure
              levels of chemicals involved in normal
              prostate function and cancer
For what does prostate MRI look?
David
Geffen
School of
             Location and amount (and possibly
Medicine
              aggressiveness) of cancer in the
              prostate
             Spread of prostate cancer
               Seminal vesicles and neurovascular
                bundle (nerves that run along prostate)
               Lymph nodes
               Bones
Prostate MRI–
David
            the Holy Grail of Prostate Imaging?
Geffen
School of
             Prostate MRI involves lying motionless
Medicine
              on a table for about an hour
             The only needles involved are an IV
              and an injection of a drug for cramps
             Resolution and contrast are superior
              to ultrasound and CT scanning
             Completely safe except in rare cases
               Pacemaker
               Claustrophobia
               Kidney failure
Prostate MRI–
David
            Anatomical Characterization
Geffen
School of
             Conventional MRI techniques,
Medicine
              combined with the optimized signal-
              to-noise ratio achieved with the
              endorectal coil, provides high
              resolution images of the prostate
             These images are used to look at the
              area around the prostate for invasion
              of the capsule and seminal vesicles
Criteria for Prostate Cancer on T2WI
David
Geffen       Cancer appears dark
School of
Medicine      (red arrow) against
              the bright normal
              gland
             Extension to seminal
              vesicles (gold arrow)
              indicates invasion
             Obliteration of the
              rectoprostatic angle
              (preserved, green
              arrow) would
              indicate
              extracapsular
              extension
Signs of Extracapsular Extension
David
Geffen
School of
             Gross extension beyond the
Medicine      expected prostatic capsule is
              invasion outside the prostate
             Other signs suggest capsular
              involvement or microscopic
              extension
               Broad base of contact
               Bulging
               Blurring or irregularity
             The small dots at the
              rectoprostatic angle may
              represent the nerve bundle
MRI Spectroscopy:
David
            Chemical Characterization
Geffen       MRI can determine the
School of
Medicine
              concentration of some
              chemicals, although
              the resolution is less
              than anatomic imaging       Abnormal
                                            High Normal
                Choline is a marker of    choline  High
                                            peak
                 cellular proliferation            citrate
                                                    peak
                 and is increased in
                 cancer
                                                Abnormal
                Citrate is a normal            low citrate
                 constituent of healthy            peak
                                           Normal
                 prostate cells              low
             “Spectra,” or line           choline
                                            peak
              graphs, show the
              concentration of these
              chemicals
MRI Spectroscopy:
David
            Chemical Characterization
Geffen
School of
Medicine
        Anatomic image
         showing bilateral
         PZ dark areas
        Spectra from the
         patient’s right
         shows abnormal
         spectra consistent
         with cancer
        Spectra from the
         left shows normal
         spectra most likely
         consistent with old
         inflammation
Diffusion-Weighted MRI:
David
            Cellular Density
Geffen
School of
             Prostate cancer cells are more densely
Medicine      packed than healthy cells
             This restricts free water motion in the cells
             MRI can detect motion in addition to
              chemicals
             MRI generates a map of free water motion
              (“Brownian motion”) to localize densely
              packed cells in areas of old inflammation
              which are already dark
Diffusion-Weighted
David
            MRI: Cellular Density
Geffen
School of
             The peripheral zone
Medicine      on the upper image
              is uniformly dark,
              likely from old
              inflammation
             The diffusion map
              localizes cancer to
              the patient’s right
              side
MRI Perfusion Imaging:
David
            Blood Flow Dynamics
Geffen
School of
             Cancer requires a rich blood supply
Medicine
             Tumors secrete chemicals that grow
              new blood vessels
             MRI can track contrast dye and
              identify areas of abnormal blood flow
             Fast imaging can generate snapshots
             Complex computer models can then
              generate parameters of blood flow
MRI Perfusion
David
            Imaging
Geffen       A dark area is
School of
Medicine      known proven
              cancer
             This same area has
              impaired diffusion
              = densely packed
              cells
             Abnormal perfusion
              map signifies new
              blood vessels
Prostate MRI: Holy Grail or Yet
David
            Another Drain on Health Care?
Geffen
School of
             Again, not a straightforward answer
Medicine
             Prostate MRI is probably neither, but
              has specific uses:
               Guiding biopsies
               Surveillance
               Presurgical staging for moderate-risk
                disease and minimally-invasive therapy
               Follow-up
Prostate MRI: Biopsy Guidance
David
Geffen
School of
             In the face of a rising PSA and
Medicine      negative biopsy, a “second look” is
              warranted
             MRI can pinpoint the most suspicious
              area in the prostate
             Biopsy can be done directly with MRI
              or with ultrasound/MRI image fusion
              under ultrasound guidance
Biopsies: MRI, Ultrasound, or None
David
            At All!?
Geffen
School of
             Currently, MRI has not been proven to
Medicine      exclude significant cancer
               Whether this is true is being investigated
             Most ultrasound biopsies are
              systematic, not based on imaging
              findings
             MRI-guided biopsies can target
              suspicious areas directly with
              confirmation
             But MRI machines cost as much as 10x
              as an ultrasound machine
Biopsies: MRI, Ultrasound, or Both!?
David
Geffen
School of
             New technology can fuse MRI data
Medicine
              with ultrasound
               Suspicious findings from MRI can be co-
                localized on ultrasound and biopsied
             This can expand image-guided
              biopsies to patients where MRI
              biopsies are unavailable
Prostate MRI: Active Surveillance
David
Geffen
School of
             In patients with low volume, low grade
Medicine
              disease, MRI provides two advantages
               Screen for missed areas suspicious for
                high-grade cancer
               Baseline imaging for follow-up, to look for
                subtle changes
Prostate MRI: Therapy Planning
David
Geffen
School of
             MRI provides two pieces of
Medicine
              information which are useful when
              planning surgical or radiation therapy
               Overall size and location of the prostate
                and cancer within it
               Spread of tumor beyond the prostate,
                especially into sensitive nerve bundles or
                the bladder or rectum
             MRI can also detect spread to the
              lymph nodes or bones in the pelvis
Prostate MRI: Follow-Up Rising PSA
David
Geffen
School of
             A rising PSA level after prostatectomy
Medicine      suggests recurrence of cancer
             MRI has been shown to be sensitive to
              detect recurrent cancer
               Surgical bed
               Bones
               Lymph nodes
             MRI can also detect recurrence in the
              radiation therapy field
The Dreaded Coil – Is It Necessary?
David
Geffen
School of
Medicine

             The endorectal coil improves
              image quality about 10-fold
             It is only necessary to characterize
              the prostate capsule for invasion
              near the neurovascular bundle
             It improves quality of spectroscopy
             Not needed for cancer detection
               For example, biopsy planning
Staging for Bones and Lymph Nodes
David
Geffen
School of
             The use of CT and bone scans for
Medicine
              prostate cancer staging primarily
              benefits intermediate to high risk men
             Guidelines were established over a
              decade ago and remain largely
              unchanged
            From a 2007
            article by H
            Hricak in the
            journal
            Radiology
CT Scans
David
Geffen
School of
Medicine
CT Scans for Staging
David
Geffen
School of
             Computed Tomography is a 3D X-ray
Medicine
             It is sensitive for enlarged lymph
              nodes and bony abnormalities
               It is not sensitive for spread of cancer to
                small lymph nodes
               Some bone lesions are nonspecific on CT
                – they could be cancer or benign
             IV and oral contrast improves
              detection of lymph nodes
             It does not characterize the prostate
Why Get a CT Scan?
David
Geffen
School of
             Treatment planning
Medicine
               e.g. external beam radiation therapy
             Treatment monitoring
               But PSA monitoring is cheaper
             Confirm no obvious disease outside of
              pelvis
             Confirm bone scan findings
Radionuclide Bone Scan
David
Geffen
School of
Medicine
Radionuclide Bone Scan
David
Geffen
School of
             99Tc-MDP is a radioactive compound
Medicine
              taken up in areas of bone turnover
             Reflects the body’s response to cancer,
              not the cancer itself
               Some other tumors are not “hot” on RBS
             Only detects bone metastases
             False positives in benign diseases, e.g.
              arthritis, can be identified on X-ray
             Fast, complete survey of skeleton
Why Get a Bone Scan?
David
Geffen
School of
             Treatment planning, e.g.
Medicine
               External beam radiation therapy
               Samarium-153-EDTMP or Strontium-89
             Treatment monitoring
               But PSA monitoring is cheaper
             Confirm no bone disease outside of
              pelvis
             Characterize pain
Positron Emission Tomography
David
Geffen
School of
Medicine
PET for Prostate Cancer
David
Geffen
School of
             Conventional PET scanning can often
Medicine      detect spread of higher-grade disease
             However, current PET agents are less
              good for prostate than other cancers
             Experimental agents which show
              promise have not been shown useful
              in larger studies
             Bone scans with 18Fluoride are also
              promising
PET Scans With More Specific
David
            Agents
Geffen
School of
             Conventional PET scans use an analog
Medicine
              of glucose (sugar) to highlight the
              increased metabolism of cancer
             Prostate cancer has cell surface
              receptors for testosterone
             Researchers at Sloan-Kettering at
              Cornell devised a PET agent which
              mimics testosterone
PET Scans With Testosterone-
David
            Specific Agent
Geffen
School of
             Comparison of testosterone (A) and
Medicine
              glucose (B) labeling on PET


             Some tumors are
              equally well seen
             Others are more
              obvious on the
              testosterone scan
PET Scans With Choline and Fluroide
David
Geffen
School of
Medicine

             As seen on MRI, choline is increased in
              prostate cancer
             A PET compound, 18Fluorocholine, is
              concentrated in high cellular turnover
             18Fluoride is taken up in
              most bone lesions
                 CT on right, PET on left
                 18
                     FCholine on top, 18F below
                 White arrow: benign
                 Black arrows: cancer
Magnetic Resonance Imaging Redux
David
Geffen
School of
Medicine
MRI for Lymph Nodes and Bones
David
Geffen
School of
             MRI has superior sensitivity to CT for
Medicine      bone metastases but only slightly
               Can still be confused by benign changes
             MRI is equally sensitive to CT for
              lymph nodes
               Costs more and takes longer to scan
               Still relies on lymph node enlargement
             A MRI contrast agent to detect micro-
              metastases to lymph nodes was not
              approved, but a new one is under
              review
MRI Lymph Node Imaging
David
Geffen
School of
Medicine
             Benign lymph node



             Lymph node with
              malignant
              infiltration

             Partial infiltration
            Courtesy M Harisinghani, Mass. Gen. Hospital
Take Home Points
David
Geffen
School of
             Medicine has many options for
Medicine
              imaging prostate cancer
             Which one depends on the overall risk
              level and planned treatment
             Some modalities are better for
              evaluating the prostate itself
             Others are useful for whole body
              staging
David
David
Geffen
Geffen
School of
School of
Medicine
Medicine

            Thank You For Your Attention


                     Questions?

More Related Content

What's hot

Prostate cancer modernising the diagnostic pathway 2013-06-11 by Marc Laniado
Prostate cancer   modernising the diagnostic pathway 2013-06-11 by Marc LaniadoProstate cancer   modernising the diagnostic pathway 2013-06-11 by Marc Laniado
Prostate cancer modernising the diagnostic pathway 2013-06-11 by Marc Laniado
Marc Laniado
 
Radiation Therapy - Prostate Cancer
Radiation Therapy - Prostate CancerRadiation Therapy - Prostate Cancer
Radiation Therapy - Prostate Cancer
Biancz Noveno
 
Petct In Gynecologic Cancer
Petct In Gynecologic CancerPetct In Gynecologic Cancer
Petct In Gynecologic Cancer
fondas vakalis
 

What's hot (20)

Mri in urology
Mri in urologyMri in urology
Mri in urology
 
SAR coil
SAR coilSAR coil
SAR coil
 
Renal Mass: Is there a place for Renal Biopsy ?
Renal Mass: Is there a place for Renal Biopsy ?Renal Mass: Is there a place for Renal Biopsy ?
Renal Mass: Is there a place for Renal Biopsy ?
 
Oncoimaging: prostate cancer
Oncoimaging: prostate cancerOncoimaging: prostate cancer
Oncoimaging: prostate cancer
 
Mri in urology
Mri in urologyMri in urology
Mri in urology
 
MRI Guided Trans Rectal Ultrasound Biopsy: A Molecular Approach to Diagnosing...
MRI Guided Trans Rectal Ultrasound Biopsy: A Molecular Approach to Diagnosing...MRI Guided Trans Rectal Ultrasound Biopsy: A Molecular Approach to Diagnosing...
MRI Guided Trans Rectal Ultrasound Biopsy: A Molecular Approach to Diagnosing...
 
20150317-Handbook-Full 24 pages version
20150317-Handbook-Full 24 pages version20150317-Handbook-Full 24 pages version
20150317-Handbook-Full 24 pages version
 
Prostate cancer modernising the diagnostic pathway 2013-06-11 by Marc Laniado
Prostate cancer   modernising the diagnostic pathway 2013-06-11 by Marc LaniadoProstate cancer   modernising the diagnostic pathway 2013-06-11 by Marc Laniado
Prostate cancer modernising the diagnostic pathway 2013-06-11 by Marc Laniado
 
Prostate carcinoma
Prostate carcinomaProstate carcinoma
Prostate carcinoma
 
Incidental pet ct finding in the neck
Incidental  pet ct finding in the neckIncidental  pet ct finding in the neck
Incidental pet ct finding in the neck
 
Mri in urology
Mri in urologyMri in urology
Mri in urology
 
Cancer imaging
Cancer imagingCancer imaging
Cancer imaging
 
Radiation Therapy - Prostate Cancer
Radiation Therapy - Prostate CancerRadiation Therapy - Prostate Cancer
Radiation Therapy - Prostate Cancer
 
NEOADJUVANT RADIOTHERPAY IN SOFT TISSUE SARCOMA- A DEBATE
NEOADJUVANT RADIOTHERPAY IN SOFT TISSUE SARCOMA- A DEBATENEOADJUVANT RADIOTHERPAY IN SOFT TISSUE SARCOMA- A DEBATE
NEOADJUVANT RADIOTHERPAY IN SOFT TISSUE SARCOMA- A DEBATE
 
Prostate Cancer
Prostate CancerProstate Cancer
Prostate Cancer
 
Petct In Gynecologic Cancer
Petct In Gynecologic CancerPetct In Gynecologic Cancer
Petct In Gynecologic Cancer
 
Prostate Cancer
Prostate CancerProstate Cancer
Prostate Cancer
 
Jean Michel Correas, prostate cancer use of multiparametric ultrasound imagin...
Jean Michel Correas, prostate cancer use of multiparametric ultrasound imagin...Jean Michel Correas, prostate cancer use of multiparametric ultrasound imagin...
Jean Michel Correas, prostate cancer use of multiparametric ultrasound imagin...
 
Prostate
ProstateProstate
Prostate
 
Radical Prostate Radiotherapy
Radical Prostate RadiotherapyRadical Prostate Radiotherapy
Radical Prostate Radiotherapy
 

Viewers also liked

Presentation1.pptx, radiological imaging of prostatic diseases
Presentation1.pptx, radiological imaging of prostatic diseasesPresentation1.pptx, radiological imaging of prostatic diseases
Presentation1.pptx, radiological imaging of prostatic diseases
Abdellah Nazeer
 
Prostate cancer update
Prostate cancer updateProstate cancer update
Prostate cancer update
Ahmed Tawfeek
 
Mri Guided Breast Biopsy
Mri Guided Breast BiopsyMri Guided Breast Biopsy
Mri Guided Breast Biopsy
prroblin
 
The urethra and male genital tract
The urethra and male genital tractThe urethra and male genital tract
The urethra and male genital tract
airwave12
 
Presentation1.pptx, ultrasound examination of the urinary bladder and prostate.
Presentation1.pptx, ultrasound examination of the urinary bladder and prostate.Presentation1.pptx, ultrasound examination of the urinary bladder and prostate.
Presentation1.pptx, ultrasound examination of the urinary bladder and prostate.
Abdellah Nazeer
 

Viewers also liked (20)

Imaging prostate cancer astellas
Imaging prostate cancer astellasImaging prostate cancer astellas
Imaging prostate cancer astellas
 
Amol april prostate cancer imaging
Amol april prostate cancer imagingAmol april prostate cancer imaging
Amol april prostate cancer imaging
 
Presentation1.pptx, radiological imaging of prostatic diseases
Presentation1.pptx, radiological imaging of prostatic diseasesPresentation1.pptx, radiological imaging of prostatic diseases
Presentation1.pptx, radiological imaging of prostatic diseases
 
Prostate cancer update
Prostate cancer updateProstate cancer update
Prostate cancer update
 
Mri Guided Breast Biopsy
Mri Guided Breast BiopsyMri Guided Breast Biopsy
Mri Guided Breast Biopsy
 
2016 urooncology updates
2016 urooncology updates2016 urooncology updates
2016 urooncology updates
 
Ca prostate [edmond]
Ca prostate [edmond]Ca prostate [edmond]
Ca prostate [edmond]
 
PSMA pet ct scan
PSMA pet ct scanPSMA pet ct scan
PSMA pet ct scan
 
The urethra and male genital tract
The urethra and male genital tractThe urethra and male genital tract
The urethra and male genital tract
 
Male genitaltract 4
Male genitaltract 4Male genitaltract 4
Male genitaltract 4
 
Pediatric renal tumors radiology
Pediatric renal tumors radiologyPediatric renal tumors radiology
Pediatric renal tumors radiology
 
renal cell carcinoma radiology
renal cell carcinoma radiologyrenal cell carcinoma radiology
renal cell carcinoma radiology
 
Valvular heart disease
Valvular heart disease Valvular heart disease
Valvular heart disease
 
What is interventional radiology, a brief pictorial
What is interventional radiology, a brief pictorialWhat is interventional radiology, a brief pictorial
What is interventional radiology, a brief pictorial
 
MULTI VALVULAR HEART DISEASE clinical presentation
MULTI VALVULAR HEART DISEASE clinical presentation MULTI VALVULAR HEART DISEASE clinical presentation
MULTI VALVULAR HEART DISEASE clinical presentation
 
Chest Film Part 1
Chest Film Part 1Chest Film Part 1
Chest Film Part 1
 
Presentation1.pptx, ultrasound examination of the urinary bladder and prostate.
Presentation1.pptx, ultrasound examination of the urinary bladder and prostate.Presentation1.pptx, ultrasound examination of the urinary bladder and prostate.
Presentation1.pptx, ultrasound examination of the urinary bladder and prostate.
 
Rotator cuff
Rotator cuffRotator cuff
Rotator cuff
 
Renal tuberculosis radiology
Renal tuberculosis radiologyRenal tuberculosis radiology
Renal tuberculosis radiology
 
Prostate Biopsy--New Emerging Trends, Dr. Muhammad Bin Zulfiqar
Prostate Biopsy--New Emerging Trends, Dr. Muhammad Bin Zulfiqar Prostate Biopsy--New Emerging Trends, Dr. Muhammad Bin Zulfiqar
Prostate Biopsy--New Emerging Trends, Dr. Muhammad Bin Zulfiqar
 

Similar to Module 7 Dr Margolis-Mri&Imaging

Acs0308 Soft Tissue Sarcoma
Acs0308 Soft Tissue SarcomaAcs0308 Soft Tissue Sarcoma
Acs0308 Soft Tissue Sarcoma
medbookonline
 
Prostatic cancer final presentation
Prostatic cancer final presentationProstatic cancer final presentation
Prostatic cancer final presentation
Zimasa Ngqokolo
 
NERRS Sep 2013 Neuroradiology Case Answers
NERRS Sep 2013 Neuroradiology Case AnswersNERRS Sep 2013 Neuroradiology Case Answers
NERRS Sep 2013 Neuroradiology Case Answers
NERRS
 
Prostate cancer
Prostate cancerProstate cancer
Prostate cancer
Ma Icban
 
8 oncologic research
8   oncologic research8   oncologic research
8 oncologic research
Juan R Farro
 
Radiology Np Students2
Radiology Np Students2Radiology Np Students2
Radiology Np Students2
wilaran99
 
Kupelian 1st talk planning dose hyderabad 2013 (cancer ci 2013) patrick kupel...
Kupelian 1st talk planning dose hyderabad 2013 (cancer ci 2013) patrick kupel...Kupelian 1st talk planning dose hyderabad 2013 (cancer ci 2013) patrick kupel...
Kupelian 1st talk planning dose hyderabad 2013 (cancer ci 2013) patrick kupel...
Dr. Vijay Anand P. Reddy
 

Similar to Module 7 Dr Margolis-Mri&Imaging (20)

Acs0308 Soft Tissue Sarcoma
Acs0308 Soft Tissue SarcomaAcs0308 Soft Tissue Sarcoma
Acs0308 Soft Tissue Sarcoma
 
Cancer
CancerCancer
Cancer
 
Focal Ca prostate.pdf
Focal Ca prostate.pdfFocal Ca prostate.pdf
Focal Ca prostate.pdf
 
Soft tissue sarcoma
Soft tissue sarcomaSoft tissue sarcoma
Soft tissue sarcoma
 
Prostatic cancer final presentation
Prostatic cancer final presentationProstatic cancer final presentation
Prostatic cancer final presentation
 
Advanced Cancer diagnosis (2).pptx
Advanced Cancer diagnosis (2).pptxAdvanced Cancer diagnosis (2).pptx
Advanced Cancer diagnosis (2).pptx
 
NERRS Sep 2013 Neuroradiology Case Answers
NERRS Sep 2013 Neuroradiology Case AnswersNERRS Sep 2013 Neuroradiology Case Answers
NERRS Sep 2013 Neuroradiology Case Answers
 
Sciencecafe Zeist 10 Dec 2009
Sciencecafe Zeist 10 Dec 2009Sciencecafe Zeist 10 Dec 2009
Sciencecafe Zeist 10 Dec 2009
 
UMC St Radboud, Innovatieve imaging biedt grote kansen voor betere iagnostiek...
UMC St Radboud, Innovatieve imaging biedt grote kansen voor betere iagnostiek...UMC St Radboud, Innovatieve imaging biedt grote kansen voor betere iagnostiek...
UMC St Radboud, Innovatieve imaging biedt grote kansen voor betere iagnostiek...
 
Pruebas radiologicas a evitar American College of Radiology.
Pruebas radiologicas a evitar American College of Radiology. Pruebas radiologicas a evitar American College of Radiology.
Pruebas radiologicas a evitar American College of Radiology.
 
Prostate cancer
Prostate cancerProstate cancer
Prostate cancer
 
Prostate cancer
Prostate cancerProstate cancer
Prostate cancer
 
8 oncologic research
8   oncologic research8   oncologic research
8 oncologic research
 
Radiology Np Students2
Radiology Np Students2Radiology Np Students2
Radiology Np Students2
 
Kupelian 1st talk planning dose hyderabad 2013 (cancer ci 2013) patrick kupel...
Kupelian 1st talk planning dose hyderabad 2013 (cancer ci 2013) patrick kupel...Kupelian 1st talk planning dose hyderabad 2013 (cancer ci 2013) patrick kupel...
Kupelian 1st talk planning dose hyderabad 2013 (cancer ci 2013) patrick kupel...
 
 
Prostate video 2
Prostate video 2Prostate video 2
Prostate video 2
 
Prostate cancer
Prostate cancer Prostate cancer
Prostate cancer
 
Mri prostate
Mri prostateMri prostate
Mri prostate
 
Understanding cancer
Understanding cancerUnderstanding cancer
Understanding cancer
 

More from PCRI_MentoringProgram

More from PCRI_MentoringProgram (10)

Module 1 Tom Kirk-LandscapePart1
Module 1 Tom Kirk-LandscapePart1Module 1 Tom Kirk-LandscapePart1
Module 1 Tom Kirk-LandscapePart1
 
Module 2 Dr Scholz-LandscapePart2
Module 2 Dr Scholz-LandscapePart2Module 2 Dr Scholz-LandscapePart2
Module 2 Dr Scholz-LandscapePart2
 
Module 4 Dr Moyad-MensHealth
Module 4 Dr Moyad-MensHealthModule 4 Dr Moyad-MensHealth
Module 4 Dr Moyad-MensHealth
 
Module 5 Dr Scholz-Screening&Biopsy
Module 5 Dr Scholz-Screening&BiopsyModule 5 Dr Scholz-Screening&Biopsy
Module 5 Dr Scholz-Screening&Biopsy
 
Module 6 Dr Scholz-HormonalTherapies
Module 6 Dr Scholz-HormonalTherapiesModule 6 Dr Scholz-HormonalTherapies
Module 6 Dr Scholz-HormonalTherapies
 
Module 8 Dr Klotz-LowRiskPC
Module 8 Dr Klotz-LowRiskPCModule 8 Dr Klotz-LowRiskPC
Module 8 Dr Klotz-LowRiskPC
 
Module 9 Dr Scholz-IntermediateRiskPC
Module 9 Dr Scholz-IntermediateRiskPCModule 9 Dr Scholz-IntermediateRiskPC
Module 9 Dr Scholz-IntermediateRiskPC
 
Module 10 Dr Blasko-HighRiskPC
Module 10 Dr Blasko-HighRiskPCModule 10 Dr Blasko-HighRiskPC
Module 10 Dr Blasko-HighRiskPC
 
Module 11 Dr Myers-PSA Relapse
Module 11 Dr Myers-PSA RelapseModule 11 Dr Myers-PSA Relapse
Module 11 Dr Myers-PSA Relapse
 
Module12 Dr Lam-AdvancedPC
Module12 Dr Lam-AdvancedPCModule12 Dr Lam-AdvancedPC
Module12 Dr Lam-AdvancedPC
 

Module 7 Dr Margolis-Mri&Imaging

  • 1. David David Geffen Geffen School of School of Medicine Medicine Imaging for Prostate Cancer Daniel J A Margolis, MD Co-Director, Prostate MRI Assistant Professor of Radiology UCLA Geffen School of Medicine
  • 2. Imaging For Prostate Cancer: David Background Geffen School of  A 2011 Harvard study found that a Medicine quarter of men with low risk cancer received scans they did not “need”  A number of high-risk men do not get the scans needed to plan treatment  Newer modalities such as MRI and PET are not widely used
  • 3. Imaging for Prostate Cancer: David Considerations Geffen School of  Whether a man needs imaging, and Medicine what kind, is based on risk  PSA  Number and % of positive biopsies and  Grade of cancer on biopsy  Age and overall health  Imaging for staging benefits high risk more than low risk  Imaging can also be used to localize cancer within (& around) the prostate
  • 4. Imaging Types David Geffen School of  Prostate and surrounding tissue Medicine  Color power Doppler ultrasound (PDUS)  Magnetic resonance imaging (MRI)  Shear wave ultrasound elastography  Bones and lymph nodes  Computed tomography (CT)  Radionuclide (planar) bone scan (RBS)  Positron emission tomography (PET)  MRI
  • 5. Ultrasound David Geffen School of  Courtesy Duke Bahn Medicine
  • 6. Ultrasound David Geffen School of  Regular gray-scale ultrasound can Medicine identify cancer, but cannot discriminate it from benign changes  Because of the abnormal blood supply, a Doppler signal shift is seen with prostate cancer on PDUS  However, whether this results in increased detection varies by institution  Ultrasound IV contrast dye increases yield, but is not approved in the USA
  • 7. Ultrasound Elastography David Geffen School of From the Medicine American Journal of Roentgen- ology
  • 8. Ultrasound Elastography David Geffen School of  Elastography is the measurement of Medicine the stiffness of tissue  Cancers are stiffer than normal tissue  New elastographic techniques measure the shear wave tissue properties of ultrasound using Young’s modulus  Biopsy detection yield improves  This may identify men who do not need biopsies, but this is unknown
  • 9. Prostate MRI: Why? David Geffen School of  The decision to remove the prostate Medicine surgically vs. radio/chemotherapy is based primarily on clinical factors  PSA  Biopsy  Physical Examination  These factors cannot reliably tell if the cancer has spread beyond the prostate, nor on which side  Systematic biopsies can and often do miss the most aggressive tumors
  • 10. Background: Prostate Cancer David Statistics– Screening Geffen School of Medicine  Breast cancer has the mammogram  Colon cancer has colonoscopy  Courtesy AdMeTech.org
  • 11. Prostate MRI David Geffen School of Medicine Anatomy Chemical concentrations Cellular density Blood flow
  • 12. What is MRI David Geffen School of  Magnetic Resonance Imaging uses Medicine magnetic pulses to generate images of tissue in the body  Images can be based on inherent magnetic properties of tissue to delineate anatomy or on functional parameters  Blood flow  Cellular packing and disorder  Concentrations of chemicals
  • 13. Components of MRI David Geffen School of  T2-weighted imaging for anatomy Medicine  Diffusion-weighted imaging to evaluate cellular packing and disorder  Perfusion (dynamic contrast) imaging for blood flow  Spectroscopic imaging to measure levels of chemicals involved in normal prostate function and cancer
  • 14. For what does prostate MRI look? David Geffen School of  Location and amount (and possibly Medicine aggressiveness) of cancer in the prostate  Spread of prostate cancer  Seminal vesicles and neurovascular bundle (nerves that run along prostate)  Lymph nodes  Bones
  • 15. Prostate MRI– David the Holy Grail of Prostate Imaging? Geffen School of  Prostate MRI involves lying motionless Medicine on a table for about an hour  The only needles involved are an IV and an injection of a drug for cramps  Resolution and contrast are superior to ultrasound and CT scanning  Completely safe except in rare cases  Pacemaker  Claustrophobia  Kidney failure
  • 16. Prostate MRI– David Anatomical Characterization Geffen School of  Conventional MRI techniques, Medicine combined with the optimized signal- to-noise ratio achieved with the endorectal coil, provides high resolution images of the prostate  These images are used to look at the area around the prostate for invasion of the capsule and seminal vesicles
  • 17. Criteria for Prostate Cancer on T2WI David Geffen  Cancer appears dark School of Medicine (red arrow) against the bright normal gland  Extension to seminal vesicles (gold arrow) indicates invasion  Obliteration of the rectoprostatic angle (preserved, green arrow) would indicate extracapsular extension
  • 18. Signs of Extracapsular Extension David Geffen School of  Gross extension beyond the Medicine expected prostatic capsule is invasion outside the prostate  Other signs suggest capsular involvement or microscopic extension  Broad base of contact  Bulging  Blurring or irregularity  The small dots at the rectoprostatic angle may represent the nerve bundle
  • 19. MRI Spectroscopy: David Chemical Characterization Geffen  MRI can determine the School of Medicine concentration of some chemicals, although the resolution is less than anatomic imaging Abnormal High Normal  Choline is a marker of choline High peak cellular proliferation citrate peak and is increased in cancer Abnormal  Citrate is a normal low citrate constituent of healthy peak Normal prostate cells low  “Spectra,” or line choline peak graphs, show the concentration of these chemicals
  • 20. MRI Spectroscopy: David Chemical Characterization Geffen School of Medicine  Anatomic image showing bilateral PZ dark areas  Spectra from the patient’s right shows abnormal spectra consistent with cancer  Spectra from the left shows normal spectra most likely consistent with old inflammation
  • 21. Diffusion-Weighted MRI: David Cellular Density Geffen School of  Prostate cancer cells are more densely Medicine packed than healthy cells  This restricts free water motion in the cells  MRI can detect motion in addition to chemicals  MRI generates a map of free water motion (“Brownian motion”) to localize densely packed cells in areas of old inflammation which are already dark
  • 22. Diffusion-Weighted David MRI: Cellular Density Geffen School of  The peripheral zone Medicine on the upper image is uniformly dark, likely from old inflammation  The diffusion map localizes cancer to the patient’s right side
  • 23. MRI Perfusion Imaging: David Blood Flow Dynamics Geffen School of  Cancer requires a rich blood supply Medicine  Tumors secrete chemicals that grow new blood vessels  MRI can track contrast dye and identify areas of abnormal blood flow  Fast imaging can generate snapshots  Complex computer models can then generate parameters of blood flow
  • 24. MRI Perfusion David Imaging Geffen  A dark area is School of Medicine known proven cancer  This same area has impaired diffusion = densely packed cells  Abnormal perfusion map signifies new blood vessels
  • 25. Prostate MRI: Holy Grail or Yet David Another Drain on Health Care? Geffen School of  Again, not a straightforward answer Medicine  Prostate MRI is probably neither, but has specific uses:  Guiding biopsies  Surveillance  Presurgical staging for moderate-risk disease and minimally-invasive therapy  Follow-up
  • 26. Prostate MRI: Biopsy Guidance David Geffen School of  In the face of a rising PSA and Medicine negative biopsy, a “second look” is warranted  MRI can pinpoint the most suspicious area in the prostate  Biopsy can be done directly with MRI or with ultrasound/MRI image fusion under ultrasound guidance
  • 27. Biopsies: MRI, Ultrasound, or None David At All!? Geffen School of  Currently, MRI has not been proven to Medicine exclude significant cancer  Whether this is true is being investigated  Most ultrasound biopsies are systematic, not based on imaging findings  MRI-guided biopsies can target suspicious areas directly with confirmation  But MRI machines cost as much as 10x as an ultrasound machine
  • 28. Biopsies: MRI, Ultrasound, or Both!? David Geffen School of  New technology can fuse MRI data Medicine with ultrasound  Suspicious findings from MRI can be co- localized on ultrasound and biopsied  This can expand image-guided biopsies to patients where MRI biopsies are unavailable
  • 29. Prostate MRI: Active Surveillance David Geffen School of  In patients with low volume, low grade Medicine disease, MRI provides two advantages  Screen for missed areas suspicious for high-grade cancer  Baseline imaging for follow-up, to look for subtle changes
  • 30. Prostate MRI: Therapy Planning David Geffen School of  MRI provides two pieces of Medicine information which are useful when planning surgical or radiation therapy  Overall size and location of the prostate and cancer within it  Spread of tumor beyond the prostate, especially into sensitive nerve bundles or the bladder or rectum  MRI can also detect spread to the lymph nodes or bones in the pelvis
  • 31. Prostate MRI: Follow-Up Rising PSA David Geffen School of  A rising PSA level after prostatectomy Medicine suggests recurrence of cancer  MRI has been shown to be sensitive to detect recurrent cancer  Surgical bed  Bones  Lymph nodes  MRI can also detect recurrence in the radiation therapy field
  • 32. The Dreaded Coil – Is It Necessary? David Geffen School of Medicine  The endorectal coil improves image quality about 10-fold  It is only necessary to characterize the prostate capsule for invasion near the neurovascular bundle  It improves quality of spectroscopy  Not needed for cancer detection  For example, biopsy planning
  • 33. Staging for Bones and Lymph Nodes David Geffen School of  The use of CT and bone scans for Medicine prostate cancer staging primarily benefits intermediate to high risk men  Guidelines were established over a decade ago and remain largely unchanged From a 2007 article by H Hricak in the journal Radiology
  • 35. CT Scans for Staging David Geffen School of  Computed Tomography is a 3D X-ray Medicine  It is sensitive for enlarged lymph nodes and bony abnormalities  It is not sensitive for spread of cancer to small lymph nodes  Some bone lesions are nonspecific on CT – they could be cancer or benign  IV and oral contrast improves detection of lymph nodes  It does not characterize the prostate
  • 36. Why Get a CT Scan? David Geffen School of  Treatment planning Medicine  e.g. external beam radiation therapy  Treatment monitoring  But PSA monitoring is cheaper  Confirm no obvious disease outside of pelvis  Confirm bone scan findings
  • 38. Radionuclide Bone Scan David Geffen School of  99Tc-MDP is a radioactive compound Medicine taken up in areas of bone turnover  Reflects the body’s response to cancer, not the cancer itself  Some other tumors are not “hot” on RBS  Only detects bone metastases  False positives in benign diseases, e.g. arthritis, can be identified on X-ray  Fast, complete survey of skeleton
  • 39. Why Get a Bone Scan? David Geffen School of  Treatment planning, e.g. Medicine  External beam radiation therapy  Samarium-153-EDTMP or Strontium-89  Treatment monitoring  But PSA monitoring is cheaper  Confirm no bone disease outside of pelvis  Characterize pain
  • 41. PET for Prostate Cancer David Geffen School of  Conventional PET scanning can often Medicine detect spread of higher-grade disease  However, current PET agents are less good for prostate than other cancers  Experimental agents which show promise have not been shown useful in larger studies  Bone scans with 18Fluoride are also promising
  • 42. PET Scans With More Specific David Agents Geffen School of  Conventional PET scans use an analog Medicine of glucose (sugar) to highlight the increased metabolism of cancer  Prostate cancer has cell surface receptors for testosterone  Researchers at Sloan-Kettering at Cornell devised a PET agent which mimics testosterone
  • 43. PET Scans With Testosterone- David Specific Agent Geffen School of  Comparison of testosterone (A) and Medicine glucose (B) labeling on PET  Some tumors are equally well seen  Others are more obvious on the testosterone scan
  • 44. PET Scans With Choline and Fluroide David Geffen School of Medicine  As seen on MRI, choline is increased in prostate cancer  A PET compound, 18Fluorocholine, is concentrated in high cellular turnover  18Fluoride is taken up in most bone lesions  CT on right, PET on left  18 FCholine on top, 18F below  White arrow: benign  Black arrows: cancer
  • 45. Magnetic Resonance Imaging Redux David Geffen School of Medicine
  • 46. MRI for Lymph Nodes and Bones David Geffen School of  MRI has superior sensitivity to CT for Medicine bone metastases but only slightly  Can still be confused by benign changes  MRI is equally sensitive to CT for lymph nodes  Costs more and takes longer to scan  Still relies on lymph node enlargement  A MRI contrast agent to detect micro- metastases to lymph nodes was not approved, but a new one is under review
  • 47. MRI Lymph Node Imaging David Geffen School of Medicine  Benign lymph node  Lymph node with malignant infiltration  Partial infiltration Courtesy M Harisinghani, Mass. Gen. Hospital
  • 48. Take Home Points David Geffen School of  Medicine has many options for Medicine imaging prostate cancer  Which one depends on the overall risk level and planned treatment  Some modalities are better for evaluating the prostate itself  Others are useful for whole body staging
  • 49. David David Geffen Geffen School of School of Medicine Medicine Thank You For Your Attention Questions?